The genetic testing company 23andMe announced it was laying off more than 200 employees, or roughly 40% of its entire ...
On Thursday, genetics-led consumer healthcare company 23andMe Holding Co. (NASDAQ:ME) announced a business restructuring to ...
The once-high-flying firm has been beset by challenges since going public via a SPAC merger in 2021. Here’s the latest.
The DNA-testing firm said in a Tuesday SEC filing, “there is substantial doubt about the company’s ability to continue.” ...
The DNA testing company 23andMe is facing serious financial concerns and has announced major restructuring. CBS News ...
The financial struggles of genetic testing and ancestry company 23andMe are raising questions about the security of customers ...
( NewsNation) — Genetic testing company 23andMe has faced a series of struggles this year, culminating in end-of-year mass ...
Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.
Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...
In this photo illustration, a 23andMe logo seen displayed on a smartphone and in the background. The company announced Monday ...
Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...
23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...